See more : Taya Investment Co., Ltd. (TAYA.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Nutranomics, Inc. (NNRX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nutranomics, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- GeeCee Ventures Limited (GEECEE.BO) Income Statement Analysis – Financial Results
- Green Block Mining Corp. (LNK.CN) Income Statement Analysis – Financial Results
- Aoyuan Beauty Valley Technology Co.,Ltd. (000615.SZ) Income Statement Analysis – Financial Results
- Bank of America Corporation (BAC) Income Statement Analysis – Financial Results
- China Shenghai Group Limited (1676.HK) Income Statement Analysis – Financial Results
Nutranomics, Inc. (NNRX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.nutranomics.com
About Nutranomics, Inc.
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 2.85M | 1.76M | 871.00 | 59.54K | 1.79M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 5.92M | 2.82M | 1.28K | 37.98K | 900.48K | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -3.08M | -1.06M | -407.00 | 21.57K | 888.85K | 747.19K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | -108.05% | -60.39% | -46.73% | 36.22% | 49.67% | 31.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.09K | 32.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 409.38K | 514.00K | 1.65M | 2.48M | 23.57K | 14.84K | 14.25K | 39.13K | 14.25K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 15.44K | 9.63K | 76.47K | 156.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 5.39M | 776.15K | 595.10K | 595.18K | 1.72M | 2.63M | 23.57K | 14.84K | 14.25K | 39.13K | 14.25K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 5.39M | 776.15K | 595.10K | 595.18K | 1.72M | 2.66M | 23.57K | 14.84K | 14.25K | 39.13K | 14.25K |
| Cost & Expenses | 0.00 | 11.31M | 3.59M | 596.38K | 633.16K | 2.63M | 4.32M | 23.57K | 14.84K | 14.25K | 39.13K | 14.25K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.86M | 51.53K | 295.15K | 678.76K | 471.34K | 231.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 115.06K | 258.75K | 206.30K | 171.86K | 60.40K | 7.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | -4.01M | -1.57M | -595.51K | -1.56M | -738.82K | -1.93M | -23.57K | -14.84K | -14.25K | -39.13K | -5.33K |
| EBITDA Ratio | 0.00% | -293.36% | -89.84% | -68,370.84% | -963.34% | -43.35% | -79.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | -8.47M | -1.84M | -595.51K | -573.61K | -836.09K | -1.92M | -23.57K | -14.84K | -14.25K | -39.13K | -5.33K |
| Operating Income Ratio | 0.00% | -297.40% | -104.57% | -68,370.84% | -963.34% | -46.73% | -79.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 1.84M | -41.13K | -355.29K | -1.66M | -381.39K | -254.80K | 6.42K | 0.00 | 0.00 | 0.00 | -8.92K |
| Income Before Tax | 0.00 | -6.63M | -1.89M | -950.80K | -2.24M | -1.22M | -2.17M | 0.00 | 0.00 | 0.00 | 0.00 | -14.25K |
| Income Before Tax Ratio | 0.00% | -232.89% | -107.50% | -109,161.31% | -3,759.32% | -68.04% | -90.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 1.00 | -595.51 | -573.61 | 471.34K | 231.60K | 23.57K | 14.84K | 14.25K | 39.13K | 8.92K |
| Net Income | 0.00 | -6.63M | -1.89M | -950.80K | -2.24M | -1.22M | -2.17M | -23.57K | -14.84K | -14.25K | -39.13K | -23.17K |
| Net Income Ratio | 0.00% | -232.89% | -107.50% | -109,161.31% | -3,759.32% | -68.04% | -90.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 16.32B | 9.59B | 5.91B | 3.73B | 1.39B | 112.43M | 45.59M | 46.21M | 45.50M | 45.50M | 45.50M | 45.50M |
| Weighted Avg Shares Out (Dil) | 16.32B | 9.59B | 5.91B | 3.73B | 1.39B | 112.43M | 45.59M | 46.21M | 45.50M | 45.50M | 45.50M | 45.50M |
Source: https://incomestatements.info
Category: Stock Reports